| systematic review | Q1504425 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013246699 |
| P356 | DOI | 10.1007/S40336-016-0172-0 |
| P3181 | OpenCitations bibliographic resource ID | 2122674 |
| P932 | PMC publication ID | 4960274 |
| P698 | PubMed publication ID | 27512689 |
| P50 | author | Marnix G. E. H. Lam | Q88103112 |
| P2093 | author name string | M A A J van den Bosch | |
| M N G J A Braat | |||
| M Samim | |||
| P2860 | cites work | Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States | Q83150416 |
| Clinical features and surgical outcome of hepatic caudate lobe metastases from colorectal cancer | Q83164501 | ||
| Kinetics of liver volume changes in the first year after portal vein embolization | Q84078056 | ||
| A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 | ||
| Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients | Q85815651 | ||
| Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors | Q86074371 | ||
| Transportal Radioembolization as Salvage Hepatocellular Carcinoma Therapy to Maintain Liver Transplant Candidacy | Q86270601 | ||
| Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? | Q86389913 | ||
| Downstaging Hepatocellular Carcinoma with Yttrium-90 radioembolization: resection or transplantation? | Q87364379 | ||
| Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation | Q87515525 | ||
| Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy | Q87585663 | ||
| Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry | Q87899621 | ||
| Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies | Q88153699 | ||
| Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned | Q26782806 | ||
| Liver transplantation for cholangiocarcinoma: Current status and new insights | Q26783361 | ||
| Imaging-Based Liver Function Tests--Past, Present and Future | Q26800968 | ||
| Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
| The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma | Q30300388 | ||
| Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection | Q33604595 | ||
| Portal vein embolization before right hepatectomy: prospective clinical trial | Q33964114 | ||
| Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis | Q34080984 | ||
| Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. | Q34107531 | ||
| Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis | Q34203176 | ||
| Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry | Q34277755 | ||
| Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival | Q34551117 | ||
| Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study | Q34596441 | ||
| Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience | Q34630506 | ||
| Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. | Q34650742 | ||
| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 | ||
| Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases | Q36063355 | ||
| Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. | Q36580721 | ||
| Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 | ||
| Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy | Q36844084 | ||
| Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases | Q36982482 | ||
| Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections | Q37127397 | ||
| Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation | Q37241865 | ||
| Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy | Q37287048 | ||
| Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors | Q37373799 | ||
| Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. | Q53651248 | ||
| Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria | Q56991938 | ||
| Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma | Q58283601 | ||
| Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization | Q63198749 | ||
| Selective internal radiation therapy: distribution of radiation in the liver | Q69393442 | ||
| Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization | Q74300371 | ||
| Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome | Q79818901 | ||
| Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma | Q79854314 | ||
| Improving resectability of hepatic colorectal metastases: expert consensus statement | Q80218589 | ||
| Liver and intestine transplantation in the United States, 1997-2006 | Q80860837 | ||
| Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach | Q82257957 | ||
| Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization | Q82436223 | ||
| Prognostic factors and prevention of radioembolization-induced liver disease | Q45850436 | ||
| A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy | Q46131261 | ||
| Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report. | Q46132216 | ||
| Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience | Q46193138 | ||
| Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres | Q47953062 | ||
| Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria | Q50142642 | ||
| Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. | Q50802980 | ||
| Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. | Q50893067 | ||
| 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. | Q50922587 | ||
| Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report. | Q51365628 | ||
| Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible? | Q51651760 | ||
| Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. | Q51918787 | ||
| Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study. | Q53076171 | ||
| Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. | Q53444980 | ||
| 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. | Q53649756 | ||
| Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. | Q37376714 | ||
| Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years | Q37498096 | ||
| Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy | Q37582590 | ||
| Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation | Q37731736 | ||
| The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. | Q37759310 | ||
| Portal vein embolization: what do we know? | Q37968916 | ||
| Primovist, Eovist: what to expect? | Q38002724 | ||
| Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. | Q38069066 | ||
| Recent advances in the treatment of hepatocellular carcinoma | Q38090921 | ||
| Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience | Q38155625 | ||
| Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer | Q38198804 | ||
| Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma | Q38211814 | ||
| The role of bridge therapy prior to orthotopic liver transplantation | Q38237526 | ||
| Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up | Q38246198 | ||
| Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature | Q38581130 | ||
| Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma | Q38968638 | ||
| Liver resection after selective internal radiotherapy (SIRT): Proof of concept, initial survival, and safety | Q38976053 | ||
| In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
| Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. | Q39048862 | ||
| Monitoring of Total and Regional Liver Function after SIRT. | Q39166935 | ||
| One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization | Q39206964 | ||
| Comparison of Tc-99m GSA scintigraphy and CT volumetry for evaluation in portal vein embolization. | Q39233128 | ||
| Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. | Q39310997 | ||
| Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma | Q39318577 | ||
| Changing trends in the presentation of colorectal liver metastases in a single hepatobiliary tertiary referral centre over fourteen years | Q39346787 | ||
| Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. | Q39608822 | ||
| Increase in future remnant liver function after preoperative portal vein embolization | Q39761538 | ||
| Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization | Q39890824 | ||
| Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry | Q40216862 | ||
| Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry | Q40385793 | ||
| Selective internal radiation therapy for liver malignancies | Q40544799 | ||
| Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma | Q40703963 | ||
| Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables | Q40740575 | ||
| Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case | Q42015945 | ||
| Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation | Q42601023 | ||
| Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases | Q42947565 | ||
| Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study | Q43738534 | ||
| Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma. | Q44153080 | ||
| Safety of repeated yttrium-90 radioembolization | Q44200845 | ||
| Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy | Q44892536 | ||
| Salvage surgery following downstaging of unresectable hepatocellular carcinoma. | Q44992661 | ||
| Yttrium-90 radioembolization for the treatment of unresectable hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. | Q45131304 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 283-295 | |
| P577 | publication date | 2016-04-23 | |
| P1433 | published in | Clinical and translational imaging | Q26853948 |
| P1476 | title | The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review | |
| P478 | volume | 4 |
| Q89509359 | Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with 90Y-Microspheres: A Systematic Review |
| Q92980443 | Primary hepatic melanoma: A case report of computed tomography and magnetic resonance imaging findings |
| Q47563178 | Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. |
| Q94602760 | Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm |
| Q33442862 | Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors. |
| Q90040194 | Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports |
| Q50218004 | Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis. |
Search more.